Roberto Fernandez-Romero, MD
Neurology · Knoxville, TNNPI 1194839639
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $89 of the $119 with a category attached, or 74.8%. 3 manufacturers reported payments, led by Biogen at 53.4% of the total. That places this record below the midpoint for neurology clinicians in TN, where the typical reported total is $2,246.
Across 3 payments — averaging $39.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$63
- Eisai Inc.$30
- Novartis$25
Across 214 payments — averaging $1497.53 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch Health US, LLC$266K
- Biogen$43K
- Teva Pharmaceuticals USA, Inc.$11K
- Acadia Pharmaceuticals Inc$1K
What the payments were for
- Food & beverage$8975%
- Education$3025%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 1 | $63 |
| Eisai Inc. | 1 | $30 |
| Novartis | 1 | $25 |
How this compares
$119 in reported general payments places this provider in the 20th percentile of 361 neurology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Memantine Hcl | 134 | $6,024 |
| Rivastigmine | 19 | $5,362 |
| Galantamine ErGalantamine Hbr | 20 | $2,164 |
| Memantine Hcl ErMemantine Hcl | 20 | $2,162 |
| Donepezil Hcl | 215 | $1,893 |
| RivastigmineRivastigmine Tartrate | 13 | $1,089 |
| Quetiapine Fumarate | 30 | $453 |
Paid to pharmacies, not to this prescriber.
Other neurology in Knoxville
- David BrandesKnoxville$412K
- Sibyl WrayKnoxville$377K
- Joseph VaughanKnoxville$177K
- Rosanne BarkerKnoxville$40K
- Randall TrudellKnoxville$39K
- Michelle BrewerKnoxville$37K
- Samuel HunterSpring Hill$676K
- Harold MosesNashville$438K
- Lucas ElijovichMemphis$415K
- Christine HagenAlcoa$371K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.